The Cultivate(MD) Capital Fund will start investing in medical device and orthopaedic technology companies in early 2018.
US-based medical device developer Genesis Innovation Group yesterday launched a $10m fund that will focus on the medical device and orthopaedic technology sectors.
The Cultivate(MD) Capital Fund is limited to private placements. It is likely to begin searching for investment opportunities at the start of 2018 and will target early, mid and later-stage companies.
Founded in 2013, Genesis partners companies and medical inventors to develop healthcare technologies, focusing on those at the seed and pre-seed stages.
Some of the firms…
